Literature DB >> 2415032

Bullous pemphigoid and intravenous gammaglobulin.

W Godard, J C Roujeau, B Guillot, C Andre, G Rifle.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 2415032

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  High-dose intravenous immunoglobulin (hdIVIg) in the treatment of autoimmune blistering disorders.

Authors:  S Jolles
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

2.  Intravenous gamma-globulin in myasthenia gravis: interaction with anti-acetylcholine receptor autoantibodies.

Authors:  R Liblau; P Gajdos; F A Bustarret; R el Habib; J F Bach; E Morel
Journal:  J Clin Immunol       Date:  1991-05       Impact factor: 8.317

Review 3.  Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders.

Authors:  S A Schwartz
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

4.  Immediate effects of intravenous IgG administration on peripheral blood B and T cells and polymorphonuclear cells in patients with myasthenia gravis.

Authors:  L Cook; J F Howard; J D Folds
Journal:  J Clin Immunol       Date:  1988-01       Impact factor: 8.317

5.  Treatment of subepidermal immunobullous diseases.

Authors:  Donna A Culton; Luis A Diaz
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.